About the Company
Mars Inc. is an American multinational manufacturer of confectionery, pet food, and other food products and a provider of animal care services, with US$45 billion in annual sales in 2022; that year Forbes ranked the company as the fourth-largest privately held company in the United States. Headquartered in McLean, Virginia, the company is entirely owned by the Mars family. Mars operates in four business segments around the world: Mars Wrigley Confectionery (headquartered in Chicago, Illinois, with U.S. headquarters in Hackettstown and Newark, New Jersey), Petcare (Zaventem, Belgium; Poncitlán, Jalisco, Mexico; Querétaro, Mexico), Food (Rancho Dominguez, California), and MARS Edge (Germantown, Maryland), the company's life sciences division.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ANIP News
Evaluating ANI Pharmaceuticals: Insights From 5 Financial Analysts
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $77.8, with a high ...
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is favoured by institutional owners who hold 64% of the company
To get a sense of who is truly in control of ANI Pharmaceuticals, Inc. ( NASDAQ:ANIP ), it is important to understand the ...
ANI Pharmaceuticals Inc ANIP
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
ANI Pharmaceuticals gets grant for powder for oral suspension with hydrochlorothiazide for hypertension treatment
Discover ANI Pharmaceuticals' patent for a pure hydrochlorothiazide powder, perfect for hypertension treatment. Learn about the composition and pH range in this innovative oral suspension. #pharmaceut ...
ANI debuts generic Fleqsuvy
Generic Fleqsuvy is a treatment for spasticity from multiple sclerosis, spinal cord injuries and other spinal cord diseases.
ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
BAUDETTE, Minn., April 09, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Baclofen Oral Suspension, a generic version of the ...
ANI Pharmaceuticals Inc ANIP
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Baclofen Oral Suspension, a generic version of the reference listed drug (RLD) Fleqsuvy®. "The launch ...
ANI Pharmaceuticals Inc
Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.
ANI Pharmaceuticals Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Loading the latest forecasts...